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The murine norovirus (MNV) is a recently discovered mouse pathogen, representing the most common contaminant in
laboratory mouse colonies. Nevertheless, the effects of MNV infection on biomedical research are still unclear. We
tested the hypothesis that MNV infection could alter immune response in mice with acute lung infection. Here we
report that co-infection with MNV increases survival of mice with Pseudomonas aeruginosa acute lung injury and
decreases in vivo production of pro-inflammatory cytokines. Our results suggest that MNV infection can deeply modify
the parameters studied in conventional models of infection and lead to false conclusions in experimental models.Introduction
The first murine norovirus, MNV1, was isolated in 2003
from the brain of an immunocompromised mouse lacking
recombination-activating gene two and signal transducer
and activator of transcription one (RAG2/STAT1-/-) [1].
Murine noroviruses are non-enveloped, positive-strand
RNA viruses that belong to the Norovirus genus in the
Caliciviridae family. This virus is related to the human
norovirus which is estimated to be responsible for up to
90% of nonbacterial epidemic gastroenteritis worldwide
[2]. Like human norovirus, many strains of MNV have
been isolated and biological diversity among MNV strains
has also been reported [3-7]. Strains can either be rapidly
cleared in wild type animals like MNV-1 CW1, CW3, and
WU11, while CR1, CR3, CR6, CR7 and S99 have been
published to be persistent [4,5].
Today, murine norovirus is the most prevalent virus in
research mouse colonies [8]. In North America, 22.1% of
12,639 mouse sera were positive for anti-MNV-1 anti-
bodies [9]. This high prevalence was confirmed by a
serological survey in Europe [10]. Similar prevalence
rates were observed in Japan and South Korea after sero-
logical or RT-PCR analysis of murine samples [11-13].
This worldwide high prevalence provides a tremendous
potential for this virus to interfere with mouse models of* Correspondence: bguery@gmail.com
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Some studies showed that norovirus had no effect on
specific animal models. Hensley et al. have shown that
murine norovirus CR6 infection had no significant effect
on adaptive immunity to vaccinia virus or influenza A
virus [14]. Similarly, transient MNV 1 or persistent MNV-
4 norovirus infection did not alter the pathology of Sal-
monella typhimurium induced intestinal inflammation
and fibrosis in mice [15]. In another model, infection with
murine norovirus 4 did not alter helicobacter-induced in-
flammatory bowel disease in interleukin 10-/- mice [16].
However, several other studies showed potential con-
sequences of norovirus infection. Lencioni et al. found
that MNV infection could accelerate bacteria-induced
inflammatory bowel disease progression in Mdr1a-/- but
not with Smad3-/- mice [17]. Murine norovirus-1 was
also reported to promote inflammation and mortality in
mice superinfected with Escherichia coli [18].
To better understand the impact of MNV infection in
animal models of bacterial pathogenicity, we investigated
the effect of the MNV S99 strains on a Pseudomonas
aeruginosa induced lung injury model in C57BL/6 mice.
Co-infections may have unpredictable consequences
with alterations of the host immune response and poten-
tially mislead the investigator in the pathophysiological
hypothesis based on the results. This study indicates that
MNV-induced immunomodulation increases survival
and decreases in vivo production of pro-inflammatoryle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Clinical score evaluation
Score Movement Fur Temperature
0 Moving Smooth Normal
1 Low mobility
2 Prostrate Bristly Cold
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Wild-type C57BL/6 male mice, 8 to 10 weeks old, were
purchased from Janvier laboratories. The mice had free
access to a standard laboratory food diet in a half-day
light cycle exposure and temperature. Mice were housed
in a controlled Specified Pathogen Free (SPF) environ-
ment as determined by the FELASA recommendations,
in either a static micro-isolator or individually ventilated
cages. Vendor reports indicated mice were negative for
murine norovirus. All animal studies were approved by
the investigational review board of the Nord-Pas-de-Cal-
ais. All animal experiments were performed in an accre-
dited establishment (N° B59-108) according to the
governmental guidelines N°86/609/CEE.
Cell lines
Raw264.7 cells (ATCC TIB-71) purchased from the Euro-
pean Collection of Cell Cultures (ECACC) (Sigma-Al-
drich, L’isle d’Abeau Chesnes, France) were maintained in
Dulbecco’s Modified Eagle Medium, high glucose, Gluta-
MAX™ Supplement, pyruvate (DMEM) supplemented
with 10% heat inactivated fetal bovine serum (Gibco).
Virus stocks and plate assays
All experiments were performed with Murine Norovirus
S99 (Berlin/2006/DE) purchased from the Friedrich-
Loeffler Institut (Greifswald-Insel Riems, Deutchland).
Virus stocks were generated using Raw264.7 as de-
scribed previously [19]. To generate a virus stock, viral
suspensions were concentrated with Amicon Ultra-15,
PLHK Ultracel-PL Membrane, 100 kDa (Merck Milli-
pore). MNV titer was obtained by endpoint titration as
described previously and expressed as TCID50/ml ac-
cording to the Spearman-Kärber method [20,21]. The
theoretical relationship between TCID50 and plaque
forming units (PFU) is approximately 0.69 by applying
the Poisson distribution [22].
Bacterial strain
All experiments were performed with Pseudomonas aer-
uginosa strain CHA (CHA) provided by B. Toussaint
(THeREx, Grenoble, France). A single colony was inocu-
lated into Luria Bertani (LB) media and grown overnight
at 37 °C with shaking. The day of the infection, a 1/40
dilution of the overnight culture was prepared and incu-
bated 2 h at 37 °C with shaking. Bacteria were washed
twice with sterile phosphate-buffered saline (PBS). The
bacterial pellet was resuspended in PBS and optical
density was measured at A600, the desired infectiousdose was extrapolated from a standard growth curve.
Bacterial suspensions and inoculum standardization
were then determined based on spectrometry and veri-
fied by serial dilution and plating on bromocresol purple
agar (BCP; bioMérieux, Marcy l’Étoile, France).
Mouse infection pneumonia
C57BL6/J mice were infected by oral gavage with 1.107
PFU of MNV S99, control mice received PBS. Seven
days later, a pulmonary infection model was induced by
intranasal instillation of P. aeruginosa. Mice were lightly
anesthetized with inhaled sevoflurane (Forene Abbott,
Queensborough, Kent, United Kingdom), after which
40 μL of the bacterial solution were administered intra-
nasally representing a total of 2.106 CFU/mouse (except
for survival studies conducted with lethal inoculate of
5.106 CFU/mouse). Control mice received 40 μL of PBS.
All mice were sacrificed at 24 h (except for survival
studies, mice were monitored on weight and clinical
score 96 h post bacterial infection).
Clinical score
The evolution of the disease score assessing the clinical ap-
pearance of the animals was evaluated on 4 items scored
from 0 to 10 summarized in Table 1 (body temperature,
appearance of the bristle, behaviour and weight loss; 0:
healthy mice, 10 moribund mice). Clinical score = [(Fur
score + temperature score +movement score) + (% weight
loss/(−5))].
Lung injury
Alveolo-capillary membrane permeability was evaluated
by measuring Fluoresceine Isothiocyanate labeled (FITC)-
albumin leakage from the vascular compartment to the
alveolar-interstitial compartment, as previously described
[23]. Briefly, mice were sacrificed after FITC-albumin in-
jection, blood and bronchoalveolar lavage was collected.
The fluorescence ratio measured in serum and bronchoal-
veolar lavage (Excitation: 487 nm, Emission: 520 nm;
Mithras LB 940, Berthold Technologies, Bad Wildbad,
Germany) reflects alveolo-capillary permeability.
Bronchoalveolar lavage (BAL)
Lungs from each experimental group were washed with
a total of 1.5 mL PBS. The recovered lavage fluid was
centrifuged (200 g for 10 min), the cellular pellet was
washed twice with PBS. BAL samples were frozen at
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counts were performed directly by optical microscopy.
Cell monolayers were prepared with a cytocentrifugator
and stained with a Wright-Giemsa stain. Cellular types
were obtained by counting 200 cells/sample and express-
ing each type of cell as a percentage of the total number
counted.
Bacterial burden
Mouse lungs and spleens were homogenized in sterile
containers with PBS. Lung and spleen homogenates were
sequentially diluted and cultured on bromocresol purple
agar plates for 24 h to assess bacterial load.
Measurement of cytokines
Mouse cytokines, IL-6 and TNF-α were measured in
culture or BAL supernatant using enzyme-linked im-
munosorbent Assay (ELISA) kits from Peprotech.
Statistical analysis
Statistical analysis was carried out using Prism 5 soft-
ware (Graph-Pad Software, San Diego CA). Values are
expressed as mean ± SEM. Comparison groups were
analysed with the nonparametric Mann–Whitney test.
Survival curves were analysed using Log-rank (Mantel-
Cox) test. Significance was accepted at *p < 0.05; ** p <
0.01; *** p < 0.001.
Results
Murine norovirus infection increases survival of mice with
P. aeruginosa induced lung injury
To determine whether an established infection with
MNV affected P. aeruginosa infection, survival was ana-
lysed for 96 h. After 7 days of colonisation with the
virus, mice were infected by intranasal instillation of P.
aeruginosa. No mortality was observed for two control

















Figure 1 Survival analysis. WT mice were infected per os with 1.107 PFU
intranasal instillation of 5.106 CFU of P. aeruginosa or PBS. Lethality was monit
with the control PBS/PBS; **, P < 0.01 for a comparison with the control PBS/P
a comparison with PBS/CHA.P. aeruginosa induced 100% lethality in the PBS/CHA
group. Infection with MNV before P. aeruginosa was as-
sociated to a 40% survival (Figure 1).
Murine norovirus infection decreases P. aeruginosa
induced lung injury and dissemination
A dose of 2.106 CFU of P. aeruginosa was inoculated
and all the analyses were performed at 24 h after the
bacterial challenge. Control groups, PBS/PBS and MNV/
PBS, showed no body weight change and a normal clin-
ical score. In P. aeruginosa infected mice, body weight
significantly decreased and the clinical score significantly
increased compared to the PBS/PBS group. MNV pre in-
fection did not prevent body weight decrease but signifi-
cantly reduced the clinical score compared to PBS/CHA
mice (Figures 2A and B).
Regarding lung alveolar capillary permeability at 24 h,
the efflux of the protein tracer in the MNV/PBS group
was comparable to the control PBS/PBS group. In PBS/
CHA infected animals, there was a significant increase
of permeability compared to the PBS/PBS group. Mice
pre-treated with MNV and further infected with P. aeru-
ginosa presented a slight increase of permeability com-
pared to control groups but significantly lower than the
PBS/CHA group (Figure 2C).
Total cell counts in BAL were no different in PBS/PBS
and MNV/PBS groups. P. aeruginosa infection, compared
to the PBS/PBS group, induced a significant increase of
the total cell count; MNV pre infection significantly de-
creased this number (Figure 2D). The differential analysis
of the cells showed a decreased recruitment of neutrophils
and lymphocytes in the MNV/CHA group compared to
the PBS/CHA group (Figures 2E and F).
Lung bacterial loads were not significantly different
between PBS/CHA and MNV/CHA groups. P. aerugi-
nosa infection, compared to the PBS/PBS group, induced








of MNV or PBS (n = 10/group). A week later, mice were infected with
ored for 96 h after P. aeruginosa infection. *, P < 0.05 for a comparison
BS; ***, P < 0.001 for a comparison with the control PBS/PBS; °P < 0.05 for
Figure 2 Physiological and alveolar capillary evaluation. WT mice were infected per os with 1.107 PFU of MNV or PBS (n = 10/group). A week
later, mice were infected with intranasal instillation of 2.106 CFU of P. aeruginosa or PBS. Changes in body weight (A) and score diseases (B) were
evaluated and mice were sacrificed at 24 h post-infection. Lung injury was assessed by alveolar capillary barrier permeability (C) and cells from
Bronchoalveolar Lavage were counted (BAL) (D–F). *, P < 0.05; **, P < 0.01; ***, P < 0.001.
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nificantly decreased for the MNV/CHA group compared
to the PBS/CHA group (Figure 3).
Murine norovirus infection modulates P. aeruginosa
induced pro-inflammatory response
We finally analysed the synthesis of TNF alpha and
interleukin 6 under the same experimental conditions.
No difference in cytokine production was observed be-
tween the two control groups PBS/PBS and MNV/PBS.
However, the production of these two pro-inflammatory
cytokine in response to acute infection was significantly
reduced in mice pre exposed to MNV compared to the
PBS/CHA group (Figure 4).
Discussion
Murine norovirus is frequently encountered in research
mouse colonies therefore raising the question of its po-
tential influence in mouse models. Recent data showthat norovirus target immune cells. Indeed, the murine
norovirus is capable of infecting macrophages, dendritic
cells and B lymphocytes in vitro as well as in vivo [24-26].
There is evidence of extra-intestinal spread of MNV.
The cellular tropism of murine norovirus is known
for macrophages and migratory dendritic cells [5], it
is possible that norovirus diffuse into the way associ-
ated with the cells of organism. This is supported by
a recent study in which the depletion of mouse den-
dritic cells prevents the spread of murine norovirus in
mesenteric lymph nodes [27].
MNV displays tropism for myeloid cells and estab-
lishes persistent infection without causing obvious dis-
ease in immune-competent mice [25]. This tropism for
myeloid cells suggests a potential effect on inflammation
and the immune responses. For the past few years, most
of the studies focused on the interference of MNV on
biomedical mouse models of inflammatory bowel disease
(IBD). For example, ATG16L1 mice infected with MNV
Figure 3 Microbiological parameters. WT mice were infected per os with 1.107 PFU of MNV or PBS (n = 10/group). A week later, mice were
infected with intranasal instillation of 2.106 CFU of P. aeruginosa or PBS. Bacterial load in the lungs (A) and dissemination (B) assessed through
spleen or cultured lung homogenate. *, P < 0.05; **, P < 0.01; ***, P < 0.001; nd: not detected.
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ease after dextran sodium sulfate administration com-
pared to mice infected with MNV-1 CW3 [28]. In
addition, the observed phenotype is dependent on the
timing of infection. In fact, inflammatory hallmarks of
Crohn’s disease are only observed when a lap of time of
7 days between viral infection and DSS protocol are
respected and not when viral infection and DSS protocol
are experimented at the same time.
Despite the large number of published studies on MNV,
little is known regarding consequences of MNV in infec-
tious models other than the gastrointestinal tract target.
Globally, infection in mice is not dramatically altered by
MNV. In fact, MNV CR6 did not alter immune responses
in C57BL/6 mice co-infected with Friend virus [29], influ-
enza A virus [14], vaccinia virus [14] or murine cyto-
megalovirus [30]. The effect of murine norovirus 4 Ldlr
KO mouse model of atherosclerosis was found to be
dependent on the time of infection [31,32]. Therefore, the
analysis of all of these studies highlights the importance of
different variables. Indeed, the observed phenotypes are
dependent on the MNV strain, murine genetic back-
ground, and the timing of infection used in the study.Figure 4 Pro-inflammatory response. WT mice were infected per os with
infected with intranasal instillation of 2.106 CFU of P. aeruginosa or PBS. A I
BAL. *, P < 0.05; **, P < 0.01; ***, P < 0.001.Since the late twentieth century, infectious diseases
rarely affect immunocompetent hosts. The emergence of
these diseases that do not infect healthy individuals
shows that existing pathogenicity and virulence concepts
do not include the host contribution as much as the
microorganism in microbial pathogenesis and the result-
ing symptoms. To remedy this problem, a new theoretical
approach to the understanding of microbial pathogen-
esis known as the “damage-response” was proposed by
Casadevall and Pirofski [33]. This theory is based on
three principles: the pathogenesis of microbial infec-
tions is due to the interaction between the host and the
microorganism; the host prognosis is determined by the
severity of tissue damage from the host pathogen inter-
action; induced tissue damage is due to both the patho-
gen but also the response of the host. Neutrophils play
a key role in bacterial clearance but are also implicated
in the post-acute lung injury to a bacterial infection. In-
deed, the severity of these lesions is dependent on the
intensity and duration of the inflammatory process.
The role of pro-inflammatory molecules such as TNF-α
in bacterial infection is complex contributing to host
defence, but also participating in organ damage and1.107 PFU of MNV or PBS (n = 10/group). A week later, mice were
L-6 and B TNFα protein were measured by ELISA in supernatants of
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tion with MNV-1 increased lethality induced by sec-
ondary infection with E. coli, and this was mediated, in
part, by TNF-α production [18]. Interestingly, we
showed that MNV S99 could modulate the immune re-
sponse in acute lung infection and decrease mortality.
In our previous work the inoculum was comparable but
the bacterial infection was performed only 24 h after
the viral infection. Moreover the route for the bacterial
infection was also different (intraperitoneal versus in-
tranasal). The main difference is probably related to the
timing between the viral and bacterial infection. Re-
cently Kernbauer et al. have shown a protective effect
of CR6 and Ski strains of murine norovirus. Indeed, the
administration of these strains has improved the sur-
vival of mice treated with a cocktail of antibiotics sub-
jected to chemical colitis protocol. In addition, the
authors demonstrated that MNV viral infection could
provide protection against intestinal lesions induced by
C. rodentium [35].
To our knowledge, this is the first report directly test-
ing the effect of MNV S99 on a mouse model of acute
lung infection. This study demonstrates unequivocally
that MNV modulates the response to Pseudomonas aer-
uginosa induced lung injury. The S99 strain of murine
norovirus led to a reduction in the inflammatory re-
sponse that is found exaggerated and harmful for mice
only infected with the CHA strain of P. aeruginosa.
Studies have demonstrated that the MNV could dissem-
inate in the organism through the cells it infects. There-
fore, the MNV can be found in the lungs and diverting
the cellular machinery of the immune cells for replica-
tion thereby reducing the immune response. Also, this
virus can function in a manner analogous to commensal
bacteria and the presence of certain virus strains to be
beneficial for the host.
MNV is a prevalent and endemic virus in research
mouse colonies. Our studies suggest that MNV infection
can alter the survival and the immune response in a
mouse model for acute lung infection. Given the preva-
lence of MNV in animal facility research, it is now ne-
cessary to consider this unwelcomed parameter.
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